Hansa Biopharma AB - Company Profile

Powered by

All the data and insights you need on Hansa Biopharma AB in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Hansa Biopharma AB Strategy Report

  • Understand Hansa Biopharma AB position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Hansa Biopharma AB: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Hansa Biopharma AB’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Hansa Biopharma AB's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Peter Nicklin

Chairman Executive Board Since: 2022 Age: 60

Mr. Peter Nicklin is the Chairman of the Board of the company since July 2022. Mr. Nicklin also currently serves as the Chairman of Tunstall Healthcare, Sciensus, and Versantis. Previously, Peter has served as Chief Executive Officer and Member of the Board of Amann Girrbach AG from June 2017 to January 2020. Earlier, he served in the role of Corporate Vice President and EMEA President of Baxter International; he also worked in senior executive roles at Bayer Healthcare, Bristol-Myers Squibb, and Novartis.

Read Hide full bio of Peter Nicklin

Soren Tulstrup

Chief Executive Officer; President Senior Management Since: 2018 Age: 58

Mr. Soren Tulstrup has been the Chief Executive Officer of the company since March 2018. Prior to this, he served as Chief Executive Officer of Vifor Pharma AG. Mr. Tulstrup served as Senior Vice President, Global Franchise Head, MPS at Shire Pharmaceuticals. He also served as the Chief Executive Officer of Santaris Pharma A/S, now part of Roche.

Read Hide full bio of Soren Tulstrup

Evan Ballantyne

Chief Financial Officer Senior Management Since: 2024

Mr. Evan Ballantyne has been the Chief Financial Officer of the company since 2024. Prior to this he served as Senior Vice President, Chief Financial Officer at Gain Therapeutics, Inc.

Read Hide full bio of Evan Ballantyne

Achim Kaufhold

Senior Vice President; Chief Medical Officer Senior Management Since: 2020 Age: 66

Mr. Achim Kaufhold has been the Chief Medical Officer and Senior Vice President of the company since June 2020. Prior to this, he served in various senior executive positions in the departments of general management, product and business development. Prior to this, Mr. Kaufhold served as a Chief Medical Officer of Basilea from February 2010 to December 2017. Prior to this, he served as Chief Executive Officer of Affitech in 2009 and Pharmexa AS in 2008; Previously, he served as Chief Medical Officer Pharmexa from 2007 to 2008, Chiron from 2005 to 2006 and Berna Biotech AG (which is now known as Johnson & Johnson) from 2001 to 2005. Earlier, he headed the clinical development of the pediatric vaccine portfolio of GlaxoSmithKline. He currently also serves as the director of Biosergen AB.

Read Hide full bio of Achim Kaufhold

Hitto Kaufmann Ph.D

Chief Scientific Officer Senior Management Since: 2023

Mr. Hitto Kaufmann has been the Chief Scientific Officer of the company since December 2023. Prior to this, he served as a Chief Scientific Officer at Pieris Pharmaceuticals from 2019 to 2023. Previously he served leadership roles at Boehringer Ingelheim.

Read Hide full bio of Hitto Kaufmann Ph.D
Gain a 360-degree view of Hansa Biopharma AB and make more informed decisions for your business Gain a 360-degree view of Hansa Biopharma AB and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer